Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia (scientific article published on 5 November 2014)

Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant

Q72236433

Circulation of human hematopoietic cells in severe combined immunodeficient mice after Cl2MDP-liposome-mediated macrophage depletion

Q72344899

[Studies of 26 strains of Moraxella Iwoffi.]

Q75715636

Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii

Q83884910

Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea

Q95813959

Resistance in Nonfermenting Gram-Negative Bacteria: Multidrug Resistance to the Maximum

Q21710731

Combating antimicrobial resistance: policy recommendations to save lives

Q24632857

Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection

Q28478751

Gene array analysis of adrenal glands in broiler chickens following ACTH treatment

Q33502880

Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis

Q33535645

The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool

Q33552298

AB5075, a Highly Virulent Isolate of Acinetobacter baumannii, as a Model Strain for the Evaluation of Pathogenesis and Antimicrobial Treatments.

Q33709547

The ecology, biology and pathogenesis of Acinetobacter spp.: an overview.

Q34179296

Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection

Q34328536

Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center

Q34568784

The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A.

Q35139454

Global challenge of multidrug-resistant Acinetobacter baumannii

Q36095081

Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice

Q36314004

Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis

Q36457770

The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species

Q36559359

Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes

Q36569183

Phenotypic and molecular characterization of Acinetobacter baumannii clinical isolates from nosocomial outbreaks in Los Angeles County, California

Q36845404

A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain

Q37036579

Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice

Q37099423

Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options

Q37150308

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

Q37374012

New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis

Q37519869

Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.

Q37780543

Antibiotics in the clinical pipeline in 2013.

Q38133967

Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry

Q38473752

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America

Q41445493

Presence of a membrane attack complex inhibiting protein on the human epithelial cell line HeLa

Q41725914

The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor

Q42428390

Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia

Q43284715

Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii

Q58815430

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

Acinetobacter baumannii

Q3241189

microbial interaction

Q71158524

P304

page(s)

1296-1305

P577

publication date

2014-11-05

P1433

published in

Journal of Infectious Diseases

Q4051141

P1476

title

Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia

P478

volume

211

Reverse relations

cites work (P2860)

Q61805238	A Porcine Wound Model of Infection
Q54949802	A global regulatory system links virulence and antibiotic resistance to envelope homeostasis in Acinetobacter baumannii.
Q26765767	Acinetobacter baumannii Infection and IL-17 Mediated Immunity
Q64091015	Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice
Q35658881	An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance
Q35101682	Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii
Q40866140	CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein
Q39038590	Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Q89861973	Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
Q57816201	Comparative analysis of the pathogenicity between multidrug-resistant clinical isolates: isolation of highly pathogenic multidrug-resistant and experimental therapeutics with fourth-generation cephalosporin cefozopran
Q35829780	Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies
Q36256352	Current advances and challenges in the development of Acinetobacter vaccines
Q28554305	Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements
Q50940139	Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble.
Q92421046	Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR) Acinetobacter baumannii
Q41138033	Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence.
Q35235590	Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient
Q92404410	Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in Acinetobacter baumannii to Enhance Cytotoxicity and Immune Evasion
Q60909651	Identification and characterization of capsule depolymerase Dpo48 from phage IME200
Q90235208	Innate Immune Responses to Acinetobacter baumannii in the Airway
Q39218893	Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria
Q36458553	Ly6G-mediated depletion of neutrophils is dependent on macrophages
Q98202475	Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment
Q43563522	Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis
Q91989820	Natural history of Acinetobacter baumannii infection in mice
Q36167957	Neutropenia exacerbates infection by Acinetobacter baumannii clinical isolates in a murine wound model
Q46242619	Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs.
Q92576300	Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection
Q63345286	SERPINB1-mediated checkpoint of inflammatory caspase activation
Q33649288	Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1.
Q39265442	The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections
Q92404420	The Mechanisms of Disease Caused by Acinetobacter baumannii
Q36956080	The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii